Search research articles
Contact Us
Filters
Showing results (1-10 of 52) with videos related to
Page
of 6
Sort By:
Journal of Immunotherapy and Precision Oncology
|
June 6, 2022
Immune Checkpoint Inhibitors in Gastrointestinal Malignancies: What Is the Path Forward?
Vaia Florou, Ignacio Garrido-Laguna
Current Treatment Options in Oncology
|
March 10, 2018
Current and Future Directions for Angiosarcoma Therapy
Vaia Florou, Breelyn A Wilky
Current Treatment Options in Oncology
|
June 7, 2021
Current Management of Angiosarcoma: Recent Advances and Lessons From the Past
Vaia Florou, Breelyn A Wilky
Cancer Drug Resistance (Alhambra, Calif.)
|
May 18, 2022
Emerging mechanisms of immunotherapy resistance in sarcomas
Vaia Florou, Breelyn A Wilky
Current Oncology Reports
|
April 12, 2022
Clinical Development of Anti-TIGIT Antibodies for Immunotherapy of Cancer
Vaia Florou, Ignacio Garrido-Laguna
JCO Oncology Practice
|
November 4, 2020
Intravenous Leiomyomatosis: A Rare Diagnosis With Aggressive Potential
Vaia Florou, Elke Jarboe, Georgios Deftereos
The Journal of Dermatological Treatment
|
May 5, 2018
Therapeutic strategies for pigmented purpuric dermatoses: a systematic literature review
Kerasia-Maria Plachouri, Vaia Florou, Sophia Georgiou
Oncotarget
|
April 23, 2021
Immunotherapy and fatigue: what we know and what we don't know
Muhammad Azeem Khan, Vaia Florou, Umang Swami
Discovery Medicine
|
February 14, 2020
Precision medicine in gastrointestinal stromal tumors
Vaia Florou, Jonathan C Trent, Breelyn A Wilky
Future Oncology (London, England)
|
October 7, 2017
Latest advances in adult gastrointestinal stromal tumors
Vaia Florou, Breelyn A Wilky, Jonathan C Trent
Page
of 6
Search research articles
Search
Showing results (1-10 of 52) with videos related to
Sort By:
Page
of 6
Journal of Immunotherapy and Precision Oncology
|
June 6, 2022
Immune Checkpoint Inhibitors in Gastrointestinal Malignancies: What Is the Path Forward?
Vaia Florou, Ignacio Garrido-Laguna
Current Treatment Options in Oncology
|
March 10, 2018
Current and Future Directions for Angiosarcoma Therapy
Vaia Florou, Breelyn A Wilky
Current Treatment Options in Oncology
|
June 7, 2021
Current Management of Angiosarcoma: Recent Advances and Lessons From the Past
Vaia Florou, Breelyn A Wilky
Cancer Drug Resistance (Alhambra, Calif.)
|
May 18, 2022
Emerging mechanisms of immunotherapy resistance in sarcomas
Vaia Florou, Breelyn A Wilky
Current Oncology Reports
|
April 12, 2022
Clinical Development of Anti-TIGIT Antibodies for Immunotherapy of Cancer
Vaia Florou, Ignacio Garrido-Laguna
JCO Oncology Practice
|
November 4, 2020
Intravenous Leiomyomatosis: A Rare Diagnosis With Aggressive Potential
Vaia Florou, Elke Jarboe, Georgios Deftereos
The Journal of Dermatological Treatment
|
May 5, 2018
Therapeutic strategies for pigmented purpuric dermatoses: a systematic literature review
Kerasia-Maria Plachouri, Vaia Florou, Sophia Georgiou
Oncotarget
|
April 23, 2021
Immunotherapy and fatigue: what we know and what we don't know
Muhammad Azeem Khan, Vaia Florou, Umang Swami
Discovery Medicine
|
February 14, 2020
Precision medicine in gastrointestinal stromal tumors
Vaia Florou, Jonathan C Trent, Breelyn A Wilky
Future Oncology (London, England)
|
October 7, 2017
Latest advances in adult gastrointestinal stromal tumors
Vaia Florou, Breelyn A Wilky, Jonathan C Trent
Page
of 6